New method detects residual cancer cells
Amplicon fusion sites polymerase chain reaction (AFS-PCR) assay can detect and quantify human neuroblastoma cells in human blood and bone marrow samples.
Amplicon fusion sites polymerase chain reaction (AFS-PCR) assay can detect and quantify human neuroblastoma cells in human blood and bone marrow samples.
Certain DNA sequences were never suspected of having a role in cancer—until now. Cells in the most common type of solid tumor have now been found to feature massive overexpression of these sequences.
The easy-to-detect tumor suppressor PML may help distinguish benign tumors from cancers, now that researchers have found benign cells produce the PML molecule and display abundant PML bodies.
A naturally occurring protein inhibits tumor growth and metastasis into secondary organs and has the potential to be developed into an anticancer drug, scientists have found.
A new imaging technology that can show the metabolic process within a prostate tumor may give oncology clinicians immediate feedback as to whether to continue with “watchful waiting” or pursue treatment.
Treating patients with the recombinant monoclonal antibody bevacizumab carries a significant risk of venous thromboembolism (VTE), a meta-analysis has shown.